Walmart Stores Inc vs Zimmer Biomet Holdings Inc — how do they compare? Walmart Stores Inc trades at $113.12 (market cap $901.33B), while Zimmer Biomet Holdings Inc trades at $97.27 (market cap $18.55B). The key difference: Walmart Stores Inc is far larger — about 48.6× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (0.99%). Which is the better fit depends on your goals.
| WMT | ZBH | |
|---|---|---|
Market Cap | $901.33B | $18.55B |
Volume | 5,675,288 | — |
Sector | Consumer Staples | Health |
52-Week High | $134.20 | $107.71 |
52-Week Low | $96.05 | $79.58 |
Enterprise Value | $964.78B | $25.61B |
Dividend Yield | 0.87% | 0.99% |
Signals from Pluang's Aura AI — not financial advice
Walmart (WMT) stock trades at $113.26, up 1.26% today, with a neutral technical signal and strong analyst consensus. The company demonstrates robust fundamentals with revenue growth to $681.0B in 2025 and net income of $19.4B, alongside consistent earnings beats. Recent news highlights operational innovations like drone delivery expansion and AI tools, while maintaining a solid dividend.
Outlook remains positive with a $142 consensus price target, though risks include competitive pressures and margin sustainability. The stock presents a long-term opportunity given its defensive positioning and growth initiatives, but investors should monitor execution against Amazon and consumer spending trends.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Walmart Inc. operates discount stores, supercenters, and neighborhood markets. The Company offers merchandise such as apparel, house wares, small appliances, electronics, musical instruments, books, home improvement, shoes, jewelry, toddler, games, household essentials, pets, pharmaceutical products, party supplies, and automotive tools. Walmart serves customers worldwide.
Read more on WMT →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →